SEP 11, 2019 10:30 AM PDT

Genomic characterization of emerging carbapenem-resistant Klebsiella pneumoniae infections at a public hospital in Lima, Peru

Sponsored by: QIAGEN
Speaker

Abstract

In contrast to other countries in Latin America, Peru had been notoriously spared by the global dissemination of carbapenem-resistant Klebsiella pneumoniae (CR-Kp) until recently. Isolated cases of KPC-producing K. pneumoniae have been reported since 2013 in Lima. However, by 2017, rapid emergence of CR-Kp occurred  at a tertiary care hospital in Lima. Here, we  describe the molecular characteristics of the CR-Kp isolates recovered during this emergence. We conducted a retrospective study of the emerging cases of CR-Kp infections at a tertiary hospital in Lima, from July 2015 to December 2017. Kp was isolated from various samples and profiled using the VITEK system and standard biochemical tests. Whole genome sequencing was performed using an Illumina MiSeq instrument at 50–100x coverage and bioinformatic analysis was conducted using CLC Genomics Workbench v12 (QIAGEN Bioinformatics). De novo assemblies were generated to identify virulence and antibiotic resistance genes. Reference-based mappings were used to infer maximum-likelihood phylogenies from SNP alignments. Fifty-nine unique CR-Kp cases were identified during the study period. A significant increase in the number of cases was observed in 2017 compared to previous years. Carbapenemase genes of were detected in 40 isolates (95%);  24 (60%) were blaNDM-1, 13 (32%) were blaKPC-2 and 3 (8%) were blaIMP-16. Isolates carrying blaKPC were more prevalent during years 2015–2016 and blaNDM isolates were more prevalent during 2017 (p<0.0001). Multiple sequence types were identified carrying the KPC, NDM and various extended-spectrum beta-lactamases, suggesting that the increase in cases was due to infection from multiple carbapenem-resistant clones. We show that multiclonal expansion of CR-Kp strains has occurred at our institution and blaKPC has been replaced by blaNDM as the prevalent resistance mechanism since 2017.

Fiorella Krapp1,2, Coralith García1,2, Karen Ocampo2, Lizeth Astocondor2, Catherine Amaro3, Pablo
Tsukayama2,4
1 Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Peru
2 Instituto de Medicina Tropical “Alexander von Humbold”, Universidad Peruana Cayetano Heredia, Lima, Peru
3 Hospital Nacional Cayetano Heredia, Lima, Peru
4 Facultad de Ciencias, Universidad Peruana Cayetano Heredia, Lima, Peru


Show Resources
You May Also Like
JUN 28, 2022 6:45 AM PDT
JUN 28, 2022 6:45 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
JUN 16, 2022 10:00 AM PDT
JUN 16, 2022 10:00 AM PDT
Date: June 16, 2022 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CEST) Antimicrobial resistance (AMR) has emerged as a major health threat. The FED-AMR project part of the One Health European...
SEP 11, 2019 10:30 AM PDT

Genomic characterization of emerging carbapenem-resistant Klebsiella pneumoniae infections at a public hospital in Lima, Peru

Sponsored by: QIAGEN


Show Resources
Loading Comments...
Show Resources